Clinical implication of 18F-fluorodeoxyglucose PET/CT in monitoring disease activity in spondyloarthritis.
Taniguchi
Yoshinori
Y
Department of Endocrinology, Metabolism and Nephrology, Kochi Medical School, Kochi University, Kochi, Japan.
Kumon
Yoshitaka
Y
Arii
Kaoru
K
Tsugita
Makoto
M
Fukumoto
Mitsutaka
M
Ohnishi
Takenao
T
Kobayashi
Shigeto
S
Terada
Yoshio
Y
D000368:Aged; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D019788:Fluorodeoxyglucose F18; D006801:Humans; D049268:Positron-Emission Tomography / Q000379:methods*; D011859:Radiography; D013131:Spine / Q000000981:diagnostic imaging; D025241:Spondylarthritis / Q000000981:diagnostic imaging*
D000893:Anti-Inflammatory Agents; D019788:Fluorodeoxyglucose F18